Phosphate as Phosphorus

What the laboratory says this test is for

This panel is usually ordered to monitor patients with chronic kidney disease (CKD) or as part of a health examination for individuals at high risk of developing kidney diseases [1].Kidney disease is more likely to develop in individuals with certain conditions, such as high blood pressure, diabetes, heart disease, and a family history of kidney disease. Early symptoms of kidney diseases are often non-specific. This panel is commonly ordered during wellness checks and emergency-room admissions when symptoms and signs are suggestive of kidney diseases. National Kidney Foundation recommends a kidney profile containing estimated glomerular filtration rate and albumin-creatinine ratio for detecting and monitoring CKD [1].The results of this test should be interpreted in the context of pertinent clinical and family history and physical examination findings.References1. Laboratory engagement plan: transforming kidney disease detection. National Kidney Foundation Laboratory Engagement Advisory Group. Published February 2018. Accessed January 6, 2022. https://www.ascp.org/content/docs/default-source/get-involved-pdfs/istp-ckd/laboratory-engagement-plan.pdf

What the laboratory says this test is for

This panel is usually ordered to monitor patients with chronic kidney disease (CKD) or as part of a health examination for individuals at high risk of developing kidney diseases [1].Kidney disease is more likely to develop in individuals with certain conditions, such as high blood pressure, diabetes, heart disease, and a family history of kidney disease. Early symptoms of kidney diseases are often non-specific. This panel is commonly ordered during wellness checks and emergency-room admissions when symptoms and signs are suggestive of kidney diseases. National Kidney Foundation recommends a kidney profile containing estimated glomerular filtration rate and albumin-creatinine ratio for detecting and monitoring CKD [1].The results of this test should be interpreted in the context of pertinent clinical and family history and physical examination findings.References1. Laboratory engagement plan: transforming kidney disease detection. National Kidney Foundation Laboratory Engagement Advisory Group. Published February 2018. Accessed January 6, 2022. https://www.ascp.org/content/docs/default-source/get-involved-pdfs/istp-ckd/laboratory-engagement-plan.pdf

What the laboratory says this test is for

This panel is designed for individuals diagnosed as having diabetes mellitus whose kidney disease has advanced to Stage 3/4 impairment. The panel affords the opportunity to assess electrolytes, phosphorus, serum creatinine/eGFR, hemoglobin, microalbumin, parathyroid hormone, calcium, and vitamin D. The grouping of these tests, readily identifiable as elements that adhere to guideline recommendations, is intended to facilitate the ready adherence to professional society clinical practice guidelines. Components of the testing related to the Management of CKD in diabetes, as outlined in the Standards of Medical Care in Diabetes 2013. These recommendations are in broad agreement with those published by the National Kidney Foundation and the American Association of Clinical Endocrinologists.

What the laboratory says this test is for

Serum phosphorus (Phosphate) levels alone are of limited diagnostic value and should be correlated with serum calcium levels. An increased phosphorus with decreased calcium suggests either hypoparathyroidism or renal disease. A decreased phosphorus and an increased calcium suggests hyperparathyroidism or sarcoidosis. When both calcium and phosphorus are decreased diagnostic considerations include malabsorption, vitamin D deficiency and renal tubular acidosis. Increased phosphorus and normal or increased calcium suggests Milk-alkali syndrome or hypervitaminosis D.